• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

糖尿病和肾脏疾病患者的低血糖症

Hypoglycemia in Patients with Diabetes and Renal Disease.

作者信息

Alsahli Mazen, Gerich John E

机构信息

Department of Medicine, Southlake Health Center and University of Toronto Faculty of Medicine, 531 Davis Dr, Newmarket, Ontario L3Y 6P5, Canada.

Department of Medicine, University of Rochester School of Medicine, 601 Elmwood Ave, Rochester, NY 14642, USA.

出版信息

J Clin Med. 2015 May 13;4(5):948-64. doi: 10.3390/jcm4050948.

DOI:10.3390/jcm4050948
PMID:26239457
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4470208/
Abstract

This article summarizes our current knowledge of the epidemiology, pathogenesis, and morbidity of hypoglycemia in patients with diabetic kidney disease and reviews therapeutic limitations in this situation.

摘要

本文总结了我们目前对糖尿病肾病患者低血糖的流行病学、发病机制和发病率的认识，并综述了这种情况下的治疗局限性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1599/4470208/5c6598a84a87/jcm-04-00948-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1599/4470208/5c6598a84a87/jcm-04-00948-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1599/4470208/5c6598a84a87/jcm-04-00948-g001.jpg

相似文献

1
Hypoglycemia in Patients with Diabetes and Renal Disease.糖尿病和肾脏疾病患者的低血糖症
J Clin Med. 2015 May 13;4(5):948-64. doi: 10.3390/jcm4050948.
2
Hypoglycemia, chronic kidney disease, and diabetes mellitus.低血糖症、慢性肾脏病和糖尿病。
Mayo Clin Proc. 2014 Nov;89(11):1564-71. doi: 10.1016/j.mayocp.2014.07.013. Epub 2014 Oct 11.
3
Glycemic Control in Patients with Diabetic Kidney Disease; Time to Recognize Perils of Iatrogenic Hypoglycemia?Moving away from Intensive Glycemic Control.糖尿病肾病患者的血糖控制；是时候认识到医源性低血糖的危害了吗？摒弃强化血糖控制。
J Assoc Physicians India. 2018 Sep;66(9):70-75.
4
Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".糖尿病肾病：新的临床和治疗问题。意大利糖尿病学会和意大利肾脏病学会关于“糖尿病肾病的自然病程和肾功能受损的 2 型糖尿病患者的高血糖治疗”的联合立场声明。
Nutr Metab Cardiovasc Dis. 2019 Nov;29(11):1127-1150. doi: 10.1016/j.numecd.2019.07.017. Epub 2019 Oct 2.
5
Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".糖尿病肾病：新的临床和治疗问题。意大利糖尿病学会和意大利肾脏病学会关于“糖尿病肾病的自然病程和肾功能受损的 2 型糖尿病患者的高血糖治疗”的联合立场声明。
J Nephrol. 2020 Feb;33(1):9-35. doi: 10.1007/s40620-019-00650-x.
6
The impact of severe hypoglycemia on renal impairment in type 2 diabetes.严重低血糖对2型糖尿病患者肾功能损害的影响。
Diabetes Res Clin Pract. 2015 Jun;108(3):448-55. doi: 10.1016/j.diabres.2015.02.028. Epub 2015 Mar 3.
7
Hypoglycemia.低血糖症。
Endocrinol Metab Clin North Am. 2013 Dec;42(4):657-76. doi: 10.1016/j.ecl.2013.07.002.
8
Incidence and risk factors associated with hypoglycemia among patients with chronic kidney disease: A systematic review.慢性肾病患者低血糖的发生率及相关危险因素：一项系统评价
J Family Community Med. 2020 Sep-Dec;27(3):157-162. doi: 10.4103/jfcm.JFCM_304_19. Epub 2020 Sep 25.
9
Hypoglycemia-Related Hospitalizations and Mortality Among Patients With Diabetes Transitioning to Dialysis.糖尿病患者透析过渡期与低血糖相关的住院和死亡。
Am J Kidney Dis. 2018 Nov;72(5):701-710. doi: 10.1053/j.ajkd.2018.04.022. Epub 2018 Jul 20.
10
Evaluation and management of diabetic and non-diabetic hypoglycemia in end-stage renal disease.终末期肾病中糖尿病和非糖尿病低血糖的评估和管理。
Nephrol Dial Transplant. 2016 Jan;31(1):8-15. doi: 10.1093/ndt/gfv258. Epub 2015 Jul 6.

引用本文的文献

1
Nutrition is Associated with Violent and Criminal Behaviors.营养与暴力及犯罪行为有关。
Curr Nutr Rep. 2025 Jun 3;14(1):76. doi: 10.1007/s13668-025-00668-7.
2
Predictive factors of hypoglycemia in type 2 diabetes: a prospective study using machine learning.2型糖尿病低血糖的预测因素：一项使用机器学习的前瞻性研究。
Sci Rep. 2025 May 25;15(1):18143. doi: 10.1038/s41598-025-03030-7.
3
Dietary glycemic and insulin indices in association with sleep quality and duration in patients undergoing angiography.血管造影患者的饮食血糖指数和胰岛素指数与睡眠质量及时长的关系

本文引用的文献

1
Summary of Recommendation Statements.推荐声明摘要。
Kidney Int Suppl (2011). 2013 Jan;3(1):5-14. doi: 10.1038/kisup.2012.77.
2
Hypoglycemia, chronic kidney disease, and diabetes mellitus.低血糖症、慢性肾脏病和糖尿病。
Mayo Clin Proc. 2014 Nov;89(11):1564-71. doi: 10.1016/j.mayocp.2014.07.013. Epub 2014 Oct 11.
3
Effect of renal impairment on the pharmacokinetics, efficacy, and safety of albiglutide.肾功能损害对阿必鲁肽药代动力学、疗效及安全性的影响。
BMC Nutr. 2025 May 23;11(1):100. doi: 10.1186/s40795-025-01082-6.
4
Diabetes and Glucose Management in People on Hemodialysis.血液透析患者的糖尿病与血糖管理
Diabetes Spectr. 2025 Feb 14;38(1):7-18. doi: 10.2337/dsi24-0015. eCollection 2025 Winter.
5
Attitudes and practices related to hypoglycemia unawareness in patients with type 1 and type 2 diabetes.1 型和 2 型糖尿病患者低血糖意识相关的态度和实践。
J Med Life. 2024 Aug;17(8):806-811. doi: 10.25122/jml-2024-0005.
6
Safety Profiles Related to Dosing Errors of Rapid-Acting Insulin Analogs: A Comparative Analysis Using the EudraVigilance Database.速效胰岛素类似物给药错误相关的安全性概况：使用欧洲药品不良反应数据库的比较分析
Biomedicines. 2024 Oct 7;12(10):2273. doi: 10.3390/biomedicines12102273.
7
Prevalence and Risk Factors of Inappropriate Drug Dosing among Older Adults with Dementia or Cognitive Impairment and Renal Impairment: A Systematic Review.痴呆或认知障碍及肾功能损害的老年人不适当药物剂量的患病率及危险因素：一项系统评价
J Clin Med. 2024 Sep 24;13(19):5658. doi: 10.3390/jcm13195658.
8
Hyperkalemia Management with Intravenous Insulin in Patients with Reduced Kidney Function.肾功能减退患者静脉注射胰岛素治疗高钾血症
J Clin Med. 2024 Aug 28;13(17):5103. doi: 10.3390/jcm13175103.
9
Strategies to address diabetic kidney disease burden in Mexico: a narrative review by the Mexican College of Nephrologists.应对墨西哥糖尿病肾病负担的策略：墨西哥肾脏病学会的叙述性综述
Front Med (Lausanne). 2024 Jun 19;11:1376115. doi: 10.3389/fmed.2024.1376115. eCollection 2024.
10
Some patients with type 2 diabetes may benefit from intensive glycaemic and blood pressure control: A post-hoc machine learning analysis of ACCORD trial data.有些 2 型糖尿病患者可能从强化血糖和血压控制中获益：ACCORD 试验数据的事后机器学习分析。
Diabetes Obes Metab. 2024 Apr;26(4):1502-1509. doi: 10.1111/dom.15453. Epub 2024 Jan 31.
Postgrad Med. 2014 May;126(3):35-46. doi: 10.3810/pgm.2014.05.2754.
4
ATP-regulated potassium channels and voltage-gated calcium channels in pancreatic alpha and beta cells: similar functions but reciprocal effects on secretion.胰腺α细胞和β细胞中的ATP调节钾通道及电压门控钙通道：功能相似但对分泌具有相反作用
Diabetologia. 2014 Sep;57(9):1749-61. doi: 10.1007/s00125-014-3279-8. Epub 2014 Jun 7.
5
Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction.加拿大糖尿病协会2013年加拿大糖尿病预防与管理临床实践指南。引言。
Can J Diabetes. 2013 Apr;37 Suppl 1:S1-3. doi: 10.1016/j.jcjd.2013.01.009. Epub 2013 Mar 26.
6
Mechanisms of hypoglycemia-associated autonomic failure in diabetes.糖尿病中低血糖相关自主神经功能衰竭的机制
N Engl J Med. 2013 Jul 25;369(4):362-72. doi: 10.1056/NEJMra1215228.
7
Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society.低血糖与糖尿病：美国糖尿病协会和内分泌学会工作组报告。
Diabetes Care. 2013 May;36(5):1384-95. doi: 10.2337/dc12-2480. Epub 2013 Apr 15.
8
Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease.治疗慢性肾脏病患者糖尿病的药代动力学考虑因素。
Expert Opin Drug Metab Toxicol. 2013 May;9(5):529-50. doi: 10.1517/17425255.2013.777428. Epub 2013 Mar 6.
9
Defective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments.糖尿病患者的低血糖无感知和低血糖反应缺陷：机制和新兴治疗方法。
Endocrinol Metab Clin North Am. 2013 Mar;42(1):15-38. doi: 10.1016/j.ecl.2012.11.005. Epub 2012 Dec 12.
10
New and emerging pharmacologic therapies for type 2 diabetes, dyslipidemia, and obesity.新型和新兴的 2 型糖尿病、血脂异常和肥胖症的药物治疗。
Clin Ther. 2013 Jan;35(1):A3-17. doi: 10.1016/j.clinthera.2012.12.012.